Cryptosporidium has become the most important contaminant found in dri
nking water and is associated with a high risk of waterborne disease p
articularly for the immunocompromised. There have been 12 documented w
aterborne outbreaks in North America since 1985; in two of these (Milw
aukee and Las Vegas) mortality rates in the immuno-compromised ranged
from 52% to 68%. The immunofluorescence antibody assay (IFA) using epi
fluorescence microscopy has been used to examine the occurrence of Cry
ptosporidium in sewage (1 to 120 oocysts/liter), filtered secondary tr
eated wastewater (0.01 to 0.13 oocysts/liter), surface waters (0.001 t
o 107 oocysts/liter), groundwater (0.004 to 0.922 oocysts/liter) and t
reated drinking water (0.001 to 0.72 oocysts/liter). New rules are bei
ng developed (Information Collection Rule and Enhanced Surface Water T
reatment Rule) to obtain more occurrence data for drinking water syste
ms for use with new risk assessment models. Public health officials sh
ould consider a communication program to physicians treating the immun
ocompromised, nursing homes, develop a plan to evaluate cases of crypt
osporidiosis in the community, and contribute to the development of pu
blic policies that limit contamination of source waters, improve water
treatment, and protect public health.